In the early stages of the recent pandemic, clinical studies reported differing levels of effectiveness for COVID-19 vaccines.
One reason for this was that people's immune composition was continuously changing due to new SARS-CoV-2 variants, booster doses, and updated vaccine types.
However, one missing data component was needed to understand these innovative vaccines' effectiveness fully.
Recently, real-world evidence was published that supports the continued use of protein-based COVID-19 vaccines.
Read More
